Technology | Radiation Oncology | July 10, 2015

Civco Exhibiting Patient Positioning and Immobilization Solutions at AAPM 2015

Body Pro-Lok ONE highlights series of solutions for SBRT, SRS and SRT

Civco, patient positioning, immobilization, SBRT, SRS, SRT, AAPM 2015

Body Pro-Lok ONE image courtesy of Civco Medical Solutions

July 10, 2015 - Civco Medical Solutions will showcase new patient positioning and immobilization innovations to attendees of the American Association of Physicists in Medicine (AAPM) annual meeting July 12 – 16 in Anaheim, California.

Civco's new product introductions include advanced patient positioning options for stereotactic body radiation therapy (SBRT) treatment with the Body Pro-Lok ONE solution; an interface with the Protura Robotic Patient Positioning System; Universal Couchtop Long Extension solutions; and the trUpoint ARCH SRS/SRT System for magnetic resonance (MR) simulation. 

  • Body Pro-Lok ONE SBRT Immobilization

The Body Pro-Lok ONE SBRT Immobilization System allows for customized setups utilizing one bridge versus three for varying patient sizes. This advanced design features lateral and tilting offset and variable height adjustment that expands and contracts for increased linear accelerator (linac) clearance and patients that have natural rotation. The bridge secures directly to the Universal Couchtop, eliminating the need for overlays and ensuring equivalent setups between computed tomography (CT) and treatment. 

 

  • Protura Robotic Patient Positioning System

Protura software now provides an interface solution for Varian users with MOSAIQ Record and Verify systems. The new interface automatically opens patient information in Protura software when the patient is opened in MOSAIQ, and automatically loads patient shift data to match Varian's On-Board Imager (OBI) kV imaging system. Protura remotely repositions patients with robotic 6 degrees of freedom, giving users the ability to ensure sub-millimeter positioning accuracy from outside the treatment room. The Protura and Varian software interface will be demonstrated in the Civco booth throughout the meeting. 

 

  • Universal Couchtop Long Extension

Several new additions to the Universal Couchtop Long Extension family have been released, including kevlar, grid and embedded wires solutions. Universal Couchtop provides seamless imaging and treatment planning with dosimetrically matched couchtops that feature a large, junction-free and artifact-free treatment area. The profile of the Universal Couchtop allows the Body Pro-Lok ONE bridge to attach directly to the couchtop, enabling a seamlessly integrated SBRT immobilization platform. 

 

  • trUpoint ARCH SRS/SRT System

trUpoint ARCH has received U.S. Food and Drug Administration (FDA) 510(k) clearance for MR environments and centers using MR simulation for stereotactic radiosurgery/stereotactic radiation therapy (SRS/SRT) cases. trUpoint ARCH improves the patient's experience with a non-invasive, accurate, repeatable and comfortable hold, with less than 1 mm of patient movement during intrafraction immobilization testing.

 

For more information: www.civco.com

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...